Published on Thursday May 28, 2026

Smooth Drug Development April 2026 News Release

Monthly News – April 2026

April marked steady progress across our clinical programs, with key regulatory submissions, feasibility activities, and strategic collaborations advancing across multiple regions.

Clinical and Scientific Departments News:
Phase I-IV Clinical Trials:
  • Phase I Clinical Trial – Mucopolysaccharidosis study: All subjects have completed their participation per Protocol.
  • Phase III Clinical Trial – Gynecology Study: 85 patients were randomized. 1 Site was opened.
  • Phase III Clinical Trial – topical antiseptic and wound-healing Study: Documents were submitted to the MoH, 4 SSV were conducted
  • Phase III Clinical Trial- Hepatitis Study: enrolment was closed in Uzbekistan and Pakistan.
  • Phase IV Clinical Trial – Spinal Muscular Atrophy Study: 6 more patients were included in the study.
  • Phase III HIV study: 8 new sites initiated; 15 patients screened.
Bioequivalence Portfolio Growth:
  • Prostatic Hyperplasia: The clinical phase is completed.
  • Sedative and Anti‑Anxiety: The clinical phase is completed.
  • Anti-convulsant Study: The clinical phase is completed.
  • Type 2 Diabetes: The clinical phase is completed
  • Bacteriostatic Drug: Screening is scheduled for 31st March 2026.
  • Urology BE: 8 patients screened.
  • Psychiatry (BE): 40 out of 48 patients enrolled
  • Endocrinology (BE) Trial 1: Site Close-Out Visit completed on 12th March 2026.
  • Endocrinology (BE) Trial 2: 57 screened; 50 randomized.

Business Development News:

Our Business Development team has been actively expanding partnerships and exploring new opportunities through strategic discussions and conference participation:

Key Partner Engagements

• We attended and participated in multiple meetings with pharmaceutical and biotechnology companies and also co-hosted a dedicated session for Pakistan and Bangladesh in BioChina 2026 on 13th March 2026. 

Looking forward to meet you in upcoming conferences: 

Global Clinical Trials Connect, London UK, 27-28 May 2026

BioChina US Forum, June 21, 2026 San Diego, USA

Bio International Convention, June 22-25, 2026, San Diego, USA 

World Vaccine Congress Europe 2026, 19-21 Oct, Amsterdam


Smooth Drug Development April 2026 News Release